Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Mitotech reports VISTA-2 data on SkQ1 for dry eye disease

March 1, 2021

Opthea prepares to begin pivotal phase III trials of OPT-302 in wet AMD

Feb. 24, 2021

FDA clears IND for phase III trial of OT-101 for myopia

Feb. 24, 2021

Phase I/II results presented for GT-005 in geographic atrophy

Feb. 19, 2021

Roche presents phase III data for faricimab in patients with DME and nAMD

Feb. 15, 2021

Last patient completes final visit for NORSE THREE safety study of ONS-5010

Feb. 12, 2021

Sinocelltech discloses new anti-VEGF antibodies

Feb. 12, 2021

Trefoil initiates phase II study of TTHX-1114 for Fuchs endothelial corneal dystrophy

Feb. 10, 2021

Surface Ophthalmics initiates phase II trial of SURF-200 for acute dry eye

Feb. 8, 2021

HIV and AMD

Feb. 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...